Risk for recurrent prostate cancer: new data

A news item this morning on the NBC web site (and probably elsewhere too) states that a new study just published in JAMA Oncology can help to “determine whether a man’s prostate cancer will come back and kill him after treatment.” We are studying the actual paper and will be commenting on this further later today.

All the lutetium-177 news that’s fit to discuss (when it first comes out)

There has been a lot of noise in the past week about the effectiveness of lutetium-177 linked to PSMA in the treatment of late stage prostate cancer. If you were looking for us to say something about this, Allen Edel already has, back in October last year, when the relevant article was first published on line and Allen promptly commented (click here to get his take).

Axumin-enhanced PET scans becoming more widely available

Because the new imaging agent known as [18F]fluciclovine (Axumin®) is the only such imaging agent approved for use in the US — other than the [11C]choline imaging agent (use of which is limited to the Mayo Clinic) — we have been monitoring access to this new agent with some interest. … READ MORE …

A better way to grow prostate cancer cells in the lab

In a very interesting research development, a group at Georgetown University here in the US has finally found a way to be able to extract and grow the normal and cancerous prostate cells from individual patients in the laboratory and then implant them into mice. … READ MORE …

What’s on the agenda for the GU Oncology Symposium in February?

We can now get a pretty good idea of the topics that will be discussed at the upcoming Genitourinary Cancers Symposium, to be held on February 16-18 next year in Orlando, Florida. … READ MORE …

What does the 21st Century Cures Act mean for prostate cancer research?

Yesterday, President Obama signed into law the 21st Century Cures Act — one of the few pieces of major legislation to get passed into law in the past 12 months with significant support from both political parties here in the US. … READ MORE …

As of Monday this week (until December 12), you can vote (once a day) for The “New” Prostate Cancer InfoLink as one of the best health care blog sites on Healthline’s Annual Best Health Blog Contest! Check it out.

As of now we have one vote in … but there don’t seem to be many people voting yet, so if we could get a couple of hundred in … :O)